FDA Inspection 1273458 — UCLA Medical IRB 1 (OHRPP)
The FDA completed an inspection of UCLA Medical IRB 1 (OHRPP) on June 4, 2025 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 4, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Los Angeles, CA (United States)
Additional Details
IRB